Alnylam Pharmaceuticals, Inc. (ALNY)
156.65
-3.20
(-2.00%)
USD |
NASDAQ |
Nov 12, 16:00
157.66
+1.01
(+0.64%)
After-Hours: 07:17
Alnylam Pharmaceuticals Max Drawdown (5Y) : 66.41% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 66.41% |
| September 30, 2026 | 58.17% |
| August 31, 2026 | 58.17% |
| July 31, 2026 | 58.17% |
| June 30, 2026 | 43.39% |
| May 31, 2026 | 42.46% |
| April 30, 2026 | 42.46% |
| March 31, 2026 | 42.46% |
| February 28, 2026 | 42.46% |
| January 31, 2026 | 42.46% |
| December 31, 2025 | 42.46% |
| November 30, 2025 | 42.46% |
| October 31, 2025 | 42.46% |
| September 30, 2025 | 42.46% |
| August 31, 2025 | 42.46% |
| July 31, 2025 | 42.46% |
| June 30, 2025 | 42.46% |
| May 31, 2025 | 42.46% |
| April 30, 2025 | 42.46% |
| March 31, 2025 | 42.46% |
| February 28, 2025 | 42.46% |
| January 31, 2025 | 42.46% |
| December 31, 2024 | 42.46% |
| November 30, 2024 | 42.46% |
| October 31, 2024 | 42.46% |
| Date | Value |
|---|---|
| September 30, 2024 | 49.18% |
| August 31, 2024 | 49.84% |
| July 31, 2024 | 51.93% |
| June 30, 2024 | 52.27% |
| May 31, 2024 | 54.98% |
| April 30, 2024 | 55.66% |
| March 31, 2024 | 55.66% |
| February 29, 2024 | 55.66% |
| January 31, 2024 | 55.66% |
| December 31, 2023 | 55.66% |
| November 30, 2023 | 57.81% |
| October 31, 2023 | 57.81% |
| September 30, 2023 | 57.81% |
| August 31, 2023 | 57.81% |
| July 31, 2023 | 57.81% |
| June 30, 2023 | 57.81% |
| May 31, 2023 | 57.81% |
| April 30, 2023 | 57.81% |
| March 31, 2023 | 57.81% |
| February 28, 2023 | 57.81% |
| January 31, 2023 | 57.81% |
| December 31, 2022 | 57.81% |
| November 30, 2022 | 57.81% |
| October 31, 2022 | 57.81% |
| September 30, 2022 | 57.81% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Ionis Pharmaceuticals, Inc. | 70.27% |
| Vertex Pharmaceuticals, Inc. | 40.15% |
| Pfizer Inc. | 58.95% |
| BridgeBio Pharma, Inc. | 92.80% |
| Cerenome, Inc. | 99.92% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -6.671 |
| Beta (5Y) | 0.4250 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 52.47% |
| Historical Sharpe Ratio (5Y) | -0.0606 |
| Historical Sortino (5Y) | -0.1347 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 17.53% |